QR Report will be out in Aug ...should be good

NOTION IS ALSO A TECH STOCK ...BUY BUY BUY

MCO is lifted, and no shortage of face masks

D'ont sell to the sharks. Hold tight and make another limit up

MCO lifted already...so no more ban

Jack Sparrow Technical analysis Notion is worth RM3:00 https://ibb.co/G5CQnBq
Resistant already breakout, if tomorrow gap up another limit up again and again
05/08/2020 4:23 PM
A GOOD ONE

That is. The door has been closed for those who did not buy before 1.44
Now tomorrow another limit up...
Congratulate for those who did't sell and big win tomorrow same for those who bought before 1.44

That is. The door has been closed for those who did not buy before 1.44
Now tomorrow another limit up...
Congratulate for those who did't sell and big win tomorrow

TOMORROW WILL MAKE 30% PROFIT AGAIN ....IF YOU BUY SUPERMAX YOU MAKE ONLY 5% OR SO

TOMORROW LIMIT UP AGAIN ....MAKING 40 CENTS ...BETTER THAN BUY SUPERMAX

BUY BUY BUY BUY BEFORE 1.44 AFTER THAT YOU CANNOT GET TO BUY LOWER PRICE

Hello 888next, does that mean only one price to buy or sell?????

Freezing of Price
"Where an Upper Limit Price or Lower Limit Price is reached on a market day and is followed by another Upper Limit Price or Lower Limit Price, as the case may be on the next market day, the Exchange may maintain the trading price at the Last Done Price of the previous market day (“the said Last Done Price”) for such period as specified by the Exchange." Item 5.4, Chapter 5 of Bursa Trading Manual
04/08/2020 9:50 PM

Does that mean only one price ????? @ 1.44 which is the last done price to buy or sell??????

some analysts will lower target price tomorrow

some analysts will down grade it to sell

be very careful....share market is like that

BlameMeLor limit down 17.4 ? tomorrow 14.8 ?
04/08/2020 1:52 PM
something like that

If got chance, better sell first cos Bursa system may be crushed as many rush out

Harta qt profit is 221 mil only.
Better be careful ...may limit down in the afternoon

limit down in the afternoon

PAT must be 500MIL to justify the current share price of 19 ringgit

100m + is worst than last qtr profit...HOW COME?????

coolcoolcool rakuten is basically shit
04/08/2020 11:56 AM

What happen?????

UOBKH target price for TOP is 36 ringgit

next come bonus issue, so better hold

SIFU TERRENCE775 will BURSA share price up at least 1 ringgit after lunch///

terence775 Bursa QR out. Congratulations. EPS 10.7 sen, slightly below my estimate. A very commendable 86mil profit, and dividend announce 17.2 sen.
28/07/2020 1:17 PM

SIFU TERENCE775 BEST ESTIMATE

with div about 18 sen

high dividend pay out may be 40 cents

kakibulldogs
64 posts
Posted by kakibulldogs > Jul 23, 2020 1:08 PM | Report Abuse

ahwong, my calculation is based on this contract, havent sum up all bio alpha others profit price range should be 0.60-0.70

Hi kaki, you calculation is very conservative of 10 pecent. Pls note that chinese medicine mark up is about 50%

However we keep the target price of 62 cents for the time being.
BUY BUY BUY BUY BUY BUY BUY BUY

BUY BUY BUY BUY BUY BUY

kakibulldogs
64 posts
Posted by kakibulldogs > Jul 23, 2020 1:08 PM | Report Abuse

ahwong, my calculation is based on this contract, havent sum up all bio alpha others profit price range should be 0.60-0.70

Hi kaki, you calculation is very conservative of 10 pecent. Pls note that chinese medicine mark up is about 50%

However we keep the target price of 62 cents for the time being.
BUY BUY BUY BUY BUY BUY BUY BUY

kakibulldogs
62 posts
Posted by kakibulldogs > Jul 23, 2020 12:38 PM | Report Abuse

sorry if i am wrong with previous revenue of 70.1M per year and nett profit of 11.6M

http://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=...

since this new contract secured : 426.7M per year
https://www.nst.com.my/business/2020/07/610728/bioalpha-bags-rm21-bill...

lets assume the nett profit will be 70.1M / 11.6M = 6

we take 426.7M / 10 ( conservative abit for costing) = 42.67M

with outstanding of 1041M shares

EPS = 42.67/1041 * PE (15) = target share price for PE 15 = 0.62

THAT MEANS THE TARGET PRICE FOR EVERYONE IS 62 cents

BUY BUY BUY BUY BUY BUY

since this new contract secured : 426.7M per year
https://www.nst.com.my/business/2020/07/610728/bioalpha-bags-rm21-bill...

lets assume the nett profit will be 70.1M / 11.6M = 6

we take 426.7M / 10 ( conservative abit for costing) = 42.67M

with outstanding of 1041M shares

EPS = 42.67/1041 * PE (15) = target share price for PE 15 = 0.62

This estimate is about correct

ya, sky is the limit. BUY BUY BUY BUY BUY

PINTU BELAKANG BURSA

TOP stock suspended ?????

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

BANKS forecast TOP qt PAT RM1.0 bil from RM347mil
Superm qt PAT RM410 mil from RM72 mil

These forecast will not make current share price of TOP and SUPERM
sustainable.

Wharton professor Jeremy Siegel told CNBC the arrival of a coronavirus vaccine is closer than markets think.
"We may find ourselves with a workable vaccine for high risk individuals by the end of the fall, early winter," he said on the news platform's "Trading Nation."
"We've had almost no setbacks in the schedule developing the vaccine, and I think that's where upside surprises can occur," he added.
His comments came as Moderna reported progress towards a workable vaccine this week.
Visit Business Insider's homepage for more stories.
A coronavirus vaccine is closer than markets think, Wharton finance professor Jeremy Siegel told CNBC on Tuesday.
"We've had almost no setbacks in the schedule developing the vaccine, and I think that's where upside surprises can occur," Siegel said on CNBC's Trading Nation.
"We may find ourselves with a workable vaccine for high risk individuals by the end of the fall, early winter."

Wharton professor Jeremy Siegel told CNBC the arrival of a coronavirus vaccine is closer than markets think.
"We may find ourselves with a workable vaccine for high risk individuals by the end of the fall, early winter," he said on the news platform's "Trading Nation."
"We've had almost no setbacks in the schedule developing the vaccine, and I think that's where upside surprises can occur," he added.
His comments came as Moderna reported progress towards a workable vaccine this week.
Visit Business Insider's homepage for more stories.
A coronavirus vaccine is closer than markets think, Wharton finance professor Jeremy Siegel told CNBC on Tuesday.
"We've had almost no setbacks in the schedule developing the vaccine, and I think that's where upside surprises can occur," Siegel said on CNBC's Trading Nation.
"We may find ourselves with a workable vaccine for high risk individuals by the end of the fall, early winter."

KYY, RHB over estimating PAT, so these PAT is not achievable:
TOP PAT 1 billions per qt----too high, jump from previous PAT 347 mil

SuperM PAT 410 mil, jump from previuos qt PAT 72 MIL

PAT picked from the air to trap you

TOP last qt profit 347 mil, RHB forecast coming qt profit at RM1.0 bil
way way way too high --- not achievable

CURRENT SHARE PRICES not sustainable

KYY, RHB over estimating PAT, so these PAT is not achievable:
TOP PAT 1 billions per qt----too high, jump from previous PAT 347 mil

SuperM PAT 410 mil, jump from previuos qt PAT 72 MIL

PAT picked from the air to trap you

TOP last qt profit 347 mil, RHB forecast coming qt profit at RM1.0 bil
way way way too high --- not achievable

CURRENT SHARE PRICES not sustainable---cooked up way way way too high

KYY, RHB over estimating PAT, so these PAT is not achievable:
TOP PAT 1 billions per qt----too high, jump from previous PAT 347 mil

SuperM PAT 410 mil, jump from previuos qt PAT 72 MIL

PAT picked from the air to trap you

TOP last qt profit 347 mil, RHB forecast coming qt profit at RM1.0 bil
way way way too high --- not achievable

CURRENT SHARE PRICES not sustainable

KYY, RHB over estimating PAT, so these PAT is not achievable:
TOP PAT 1 billions per qt----too high, jump from previous PAT 347 mil
SuperM PAT 410 mil, jump from previuos qt PAT 72 MIL

PAT picked from the air to trap you

TOP last qt profit 347 mil, RHB forecast coming qt profit at RM1.0 bil
way way way too high --- not achievable